The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases
- Home
- Publications
- The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer—a report of two cases
Latest News
-
-
-
-
Prostate Cancer Survivor Stories That Inspire Hope
09 Jul, 2026 -
Seminar & Events
-
Baghdad clinic
30 Sep, 2024 -
Saudi German Hospital
26 Sep, 2024 -
Oncology Program
16 Sep, 2024 -
Oncology marketing
06 Sep, 2024 -
CAR-T THERAPY
14 Aug, 2024